Insider Transactions in Q2 2021 at Anika Therapeutics, Inc. (ANIK)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+21.23%
|
-
|
|
Jun 16
2021
|
Raymond J Land Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+25.6%
|
-
|
|
Jun 16
2021
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+20.82%
|
-
|
|
Jun 16
2021
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+23.63%
|
-
|
|
Jun 16
2021
|
Jeffery S Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+21.62%
|
-
|
|
Jun 16
2021
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,172
+20.86%
|
-
|
|
Jun 15
2021
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,994
+7.4%
|
$98,802
$33.4 P/Share
|
|
May 18
2021
|
John B Henneman Iii Director |
BUY
Open market or private purchase
|
Direct |
2,000
+15.03%
|
$84,000
$42.86 P/Share
|
|
May 12
2021
|
Raymond J Land Director |
SELL
Open market or private sale
|
Direct |
2,000
-20.09%
|
$84,000
$42.6 P/Share
|
|
Apr 26
2021
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,575
+41.62%
|
-
|